The High Point, North Carolina-based company said it had a loss of 6 cents per share.
The biopharmaceutical company posted revenue of $3.4 million in the period.
In the final minutes of trading on Thursday, the company's shares hit $2.64. A year ago, they were trading at $5.86.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VTVT at https://www.zacks.com/ap/VTVT
Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.